Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials

• Autori principali: Jingyi Hou (Autore), Ruiyang Xie (Autore), Zhuo Zhang (Autore), Qianxin Liu (Autore), Qian Xiang (Autore), Yimin Cui (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: The regimens of immune checkpoint inhibitors (ICIs) alone or with chemotherapy are emerging as systemic therapy for patients with advanced and metastatic gastrointestinal cancers. However, the risk of treatment-related hematologic toxicity stays unclear.Methods: We enrolled in phase 3 ra...